Medical Services International's VScan HIV Test Kits to be Used in Drug Rehabilitation Clinics

Article

EDMONTON, Alberta -- Medical Services

International Inc. announces that Beijing

officials have approved the shipping of VScan HIV 1&2 rapid test kits to

certain Provincial police departments to start a mandatory testing program for

HIV in drug rehabilitation facilities. This testing will be done in the form

of a clinical trial.

It has become mandatory in the majority of the provinces in the People's

Republic of China that all individuals starting drug rehabilitation programs

and prisoners suspected of using drugs to be tested for HIV. The VScan HIV 1&2

rapid test kit is the first rapid test kit to be used in this manner in China.

Medical Services has been given this opportunity as a result of the

excellent test results achieved to date during the ongoing testing of the

VScan HIV test kits related to the application for SDA approval of the VScan

test kit.

The VScan rapid test kit is a single-use, easy-to-use test for the

screening of HIV 1&2 and subgroup O, Hepatitis B&C, Tuberculosis (TB) and West

Nile.

Source: Medical Services International Inc.

Newsletter

Stay prepared and protected with Infection Control Today's newsletter, delivering essential updates, best practices, and expert insights for infection preventionists.

Recent Videos
 Brenna Doran PhD, MA, hospital epidemiology and infection prevention for the University of California, San Francisco, and a coach and consultant of infection prevention; Jessica Swain, MBA, MLT, director of infection prevention and control for Dartmouth Health in Lebanon, New Hampshire; and Shanina Knighton, associate professor at Case Western Reserve University School of Nursing and senior nurse scientist at MetroHealth System in Cleveland, Ohio
 Brenna Doran PhD, MA, hospital epidemiology and infection prevention for the University of California, San Francisco, and a coach and consultant of infection prevention; Jessica Swain, MBA, MLT, director of infection prevention and control for Dartmouth Health in Lebanon, New Hampshire; and Shanina Knighton, associate professor at Case Western Reserve University School of Nursing and senior nurse scientist at MetroHealth System in Cleveland, Ohio
In a recent discussion with Infection Control Today® (ICT®), study authors Brenna Doran PhD, MA, hospital epidemiology and infection prevention for the University of California, San Francisco, and a coach and consultant of infection prevention; Jessica Swain, MBA, MLT, director of infection prevention and control for Dartmouth Health in Lebanon, New Hampshire; and Shanina Knighton, associate professor at Case Western Reserve University School of Nursing and senior nurse scientist at MetroHealth System in Cleveland, Ohio, shared their insights on how the project evolved and what the findings mean for the future.